Dashboard
With ROE of 12.8, it has a Very Expensive valuation with a 12.7 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -3.70%, its profits have risen by 15.1% ; the PEG ratio of the company is 6.6
Stock DNA
Other Chemical products
INR 50,488 Cr (Mid Cap)
99.00
23
0.20%
-0.01
12.84%
12.70
Total Returns (Price + Dividend) 
Latest dividend: 7.5 per share ex-dividend date: Aug-07-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Linde India Technical Momentum Shifts Amid Mixed Indicator Signals
Linde India’s recent price action reflects a nuanced shift in technical momentum, with a blend of mildly bullish and bearish signals across key indicators. The stock’s performance contrasts with broader market trends, highlighting evolving dynamics within the Other Chemical products sector.
Read More
Linde India Ltd. is Rated Sell by MarketsMOJO
Linde India Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 December 2025, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Linde India Technical Momentum Shifts Amid Mixed Market Signals
Linde India’s recent technical indicators reveal a shift in price momentum, reflecting a more cautious market stance amid mixed signals from key momentum and volume metrics. The stock’s performance contrasts with broader market trends, highlighting nuanced investor sentiment within the Other Chemical products sector.
Read More Announcements 
Linde India Limited - Outcome of Board Meeting
13-Nov-2019 | Source : NSELinde India Limited has informed the Exchange regarding Board meeting held on November 11, 2019.
Linde India Limited - Updates
23-Oct-2019 | Source : NSELinde India Limited has informed the Exchange regarding 'This refers to the Order dated 6 September 2018 passed by the Competition Commission of India (CCI) in connection with the Combination Registration No. C-2018/01/545 filed by Linde AG and Praxair, Inc., pursuant to which the Company had recently obtained approval of its members to sell/ transfer and divest the Company s South Region Divestment Business as more fully described in Schedule II of the Order dated 6 September 2018 issued by the CCI, together with surplus land at Chennai and Hyderabad PGP sites and a decommissioned Air Separation Unit at Hyderabad site with all related assets and liabilities including but not limited to staff, contracts, licenses, permits, consents, approvals, whatsoever, all on a slump-sale and as is where is basis to Air Water India Private Ltd., a company incorporated under the Companies Act, 2013 for an aggregate sale consideration of Rs.13,800 million (Rupees Thirteen Thousand Eight Hundred million only) in terms of the Business Transfer Agreement to be executed between the Company and the aforesaid Air Water India Private Ltd..
Reply to Clarification- Financial results
16-Sep-2019 | Source : NSE
| The Exchange had sought clarification from Linde India Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Statement of Cash Flow not submitted The response of the Company is enclosed. |
Corporate Actions 
No Upcoming Board Meetings
Linde India Ltd. has declared 45% dividend, ex-date: 07 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 27 Schemes (6.29%)
Held by 118 FIIs (2.35%)
The Boc Group Ltd., U.k. (75.0%)
Nippon Life India Trustee Ltd. Through Its Various Funds (2.86%)
12.59%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 12.80% vs -3.51% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 59.53% vs -9.48% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -5.62% vs -10.10% in Sep 2024
Growth in half year ended Sep 2025 is 26.39% vs 5.51% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -11.46% vs 18.27% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 2.36% vs -0.04% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






